World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
74
Citations
26843
World Ranking
19303
National Ranking
9618

Overview

Richard J. Gralla is affiliated with Memorial Sloan Kettering Cancer Center in the United States. Their research primarily focuses on the field of Medicine, with significant contributions in Oncology, Surgery, and Pulmonary and Respiratory Medicine. Additional areas of interest include Public Health, Environmental and Occupational Health, and Physiology.

The main topics addressed in their work comprise:

  • Nausea and vomiting management
  • Cancer survivorship and care
  • Anesthesia and Pain Management
  • Palliative Care and End-of-Life Issues
  • Lung Cancer Diagnosis and Treatment
  • Pathogenesis and Treatment of Hiccups
  • Lung Cancer Treatments and Mutations

Richard J. Gralla has published extensively in several academic journals. Frequent publication venues include:

  • Journal of Clinical Oncology
  • Supportive Care in Cancer
  • Clinical Oncology
  • ESMO Open
  • Current Oncology

Notable recent papers authored or co-authored by Richard J. Gralla are:

  • Supportive Care: An Indispensable Component of Modern Oncology, 2020, Clinical Oncology
  • Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non-Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy, 2023, Journal of Clinical Oncology
  • 2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting, 2024, ESMO Open
  • 2023 updated MASCC/ESMO Consensus recommendations: Prevention of nausea and vomiting following moderately emetic risk antineoplastic agents, 2023, Supportive Care in Cancer
  • Emetic risk classification and evaluation of the emetogenicity of antineoplastic agents-updated MASCC/ESMO consensus recommendation, 2023, Supportive Care in Cancer

Richard J. Gralla has collaborated frequently with several researchers. Some of their frequent co-authors include:

  • Matti Aapro
  • Paul J. Hesketh
  • Hirotoshi Iihara
  • Karin Jordan
  • Florian Scotté

Best Publications

  • Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non–Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy

    Frances A. Shepherd;Janet Dancey;Rodryg Ramlau;Karin Mattson

  • Topotecan Versus Cyclophosphamide, Doxorubicin, and Vincristine for the Treatment of Recurrent Small-Cell Lung Cancer

    Joachim von Pawel;Joan H. Schiller;Frances A. Shepherd;Scott Z. Fields

  • The Oral Neurokinin-1 Antagonist Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients Receiving High-Dose Cisplatin—The Aprepitant Protocol 052 Study Group

    Paul J. Hesketh;Steven M. Grunberg;Richard J. Gralla;David G. Warr

  • American Society of Clinical Oncology Guideline for Antiemetics in Oncology: Update 2006

    Mark G. Kris;Paul J. Hesketh;Mark R. Somerfield;Petra Feyer

  • Antiemetic Efficacy of High-Dose Metoclopramide: Randomized Trials with Placebo and Prochlorperazine in Patients with Chemotherapy-Induced Nausea and Vomiting

    Richard J. Gralla;Loretta M. Itri;Sharon E. Pisko;Anna E. Squillante

  • Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice Guidelines

    Richard J. Gralla;David Osoba;Mark G. Kris;Peter Kirkbride

  • Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference

    F. Roila;J. Herrstedt;M. Aapro;R. J. Gralla

  • Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron

    R. Gralla;M. Lichinitser;S. Van der Vegt;H. Sleeboom

  • Impact of EGFR Inhibitor in Non–Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-Analysis

    Chee Khoon Lee;Chris Brown;Richard J. Gralla;Vera Hirsh

  • 2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients

    F. Roila;A. Molassiotis;J. Herrstedt;M. Aapro

  • Clinical and Molecular Characteristics Associated With Survival Among Patients Treated With Checkpoint Inhibitors for Advanced Non-Small Cell Lung Carcinoma: A Systematic Review and Meta-analysis.

    Chee Khoon Lee;Chee Khoon Lee;Johnathan Man;Sally Lord;Wendy Cooper;Wendy Cooper

  • Efficacy and Tolerability of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer After Moderately Emetogenic Chemotherapy

    David G. Warr;Paul J. Hesketh;Richard J. Gralla;Hyman B. Muss

  • Preoperative chemotherapy for stage IIIa (N2) lung cancer: the Sloan-Kettering experience with 136 patients.

    Nael Martini;Mark G. Kris;Betty J. Flehinger;Richard J. Gralla

  • Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer—A quantitative western blot analysis

    Josep Dalmau;Henry M. Furneaux;Richard J. Gralla;Mark G. Kris

  • Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: A randomized trial investigating two dosage schedules.

    Richard J. Gralla;Ephraim S. Casper;David P. Kelsen;David W. Braun

  • Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin

    M G Kris;R J Gralla;R A Clark;L B Tyson

  • Reduction of Cisplatin-Induced Emesis by a Selective Neurokinin-1–Receptor Antagonist

    Rudolph M. Navari;Rick R. Reinhardt;Richard J. Gralla;Mark G. Kris

  • Prevention of chemotherapy- and radiotherapy-induced emesis: Results of the 2004 Perugia International Antiemetic Consensus Conference

    Fausto Roila;Matti Aapro;Enzo Ballatori;Sussanne Borjeson

  • Quality of life assessment in individuals with lung cancer: Testing the Lung Cancer Symptom Scale (LCSS)

    Patricia J. Hollen;Richard J. Gralla;Mark G. Kris;Lisa M. Potanovich

  • Impact of Specific Epidermal Growth Factor Receptor (EGFR) Mutations and Clinical Characteristics on Outcomes After Treatment With EGFR Tyrosine Kinase Inhibitors Versus Chemotherapy in EGFR-Mutant Lung Cancer: A Meta-Analysis

    Chee Khoon Lee;Chee Khoon Lee;Yi Long Wu;Pei Ni Ding;Pei Ni Ding;Sarah J. Lord;Sarah J. Lord

Frequent Co-Authors

Mark G. Kris
Mark G. Kris Memorial Sloan Kettering Cancer Center
David P. Kelsen
David P. Kelsen Memorial Sloan Kettering Cancer Center
David Osoba
David Osoba University of British Columbia
Nael Martini
Nael Martini Memorial Sloan Kettering Cancer Center
Frances A. Shepherd
Frances A. Shepherd Princess Margaret Cancer Centre
Christopher Cox
Christopher Cox Johns Hopkins University
Matti Aapro
Matti Aapro European CanCer Organisation
Gary R. Morrow
Gary R. Morrow University of Rochester Medical Center
Jacek Jassem
Jacek Jassem Gdańsk Medical University
Edith A. Perez
Edith A. Perez Mayo Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn’t always mean committing to a traditional path. Prospective students with non-nursing backgrounds can consider direct entry msn programs for non-nursing majors, designed for those looking to transition to nursing at an accelerated pace. These programs allow you to earn a Master of Science in Nursing without prior nursing experience.

If you’re concerned about admissions requirements, you may want to review whats the easiest nursing program to get into?. Some schools offer more accessible entry points, making it easier for students from diverse backgrounds to start nursing careers.

Interested in healthcare support roles? Consider taking online medical coding classes with financial aid. Medical billing and coding is a fast-growing field that offers flexibility and strong job prospects, both on-campus and online.

For those seeking nursing options that minimize entrance exam stress, research nursing school that don't require teas. These programs eliminate the need for TEAS or HESI exam scores, streamlining your journey into healthcare.

Best Scientists Citing Richard J. Gralla

Trending Scientists

Recently Published Articles